Cysteine 98 in CYP3A4 contributes to conformational integrity required for p450 interaction with CYP reductase

被引：0
|
作者：
Wen, Bo
Huang, Christine S.
Rodrigues, A. David
Lampe, Jed N.
Atkins, William M.
Nelson, Sidney D.
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
391
引用
收藏
页码：254 / 255
页数：2
相关论文
共 50 条
  • [41] A Measurement Method for Cytochrome P450 3A4 (CYP3A4)-mediated Oxidation of Cholesterol in Lipid Membranes
    Shoji, Atsushi
    Miki, Haruka
    Kikkawa, Mikiko
    Yamamoto, Miyu
    Moriiwa, Yukiko
    Morioka, Kazuhiro
    Yanagida, Akio
    SENSORS AND MATERIALS, 2022, 34 (03) : 951 - 960
  • [42] Evaluation of Luciferin-Isopropyl Acetal as a CYP3A4 Substrate for Human Hepatocytes: Effects of Organic Solvents, Cytochrome P450 (P450) Inhibitors, and P450 Inducers
    Li, Albert P.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1598 - 1603
  • [43] Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
    Danek, Przemyslaw J.
    Basinska-Ziobron, Agnieszka
    Wojcikowski, Jacek
    Daniel, Wladyslawa A.
    PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 303 - 308
  • [44] Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes
    Natsui, Kiyohi
    Mizuno, Yoshiko
    Tani, Naoko
    Yabuki, Masashi
    Komuro, Setsuko
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2007, 32 (04) : 233 - 240
  • [45] Effects of cytostatic drugs on activity of the cytochrome P450 isoform CYP3A4 in human liver microsomes
    RaoSchymanski, RA
    Bocker, R
    Barthold, B
    Muller, A
    Fuhr, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 465 - 465
  • [46] Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
    Przemysław J. Danek
    Agnieszka Basińska-Ziobroń
    Jacek Wójcikowski
    Władysława A. Daniel
    Pharmacological Reports, 2021, 73 : 303 - 308
  • [47] Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Baylon, Javier L.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2015, 54 (13) : 2227 - 2239
  • [48] Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
    Agrawal, Vishal
    Choi, Ji Ha
    Giacomini, Kathleen M.
    Miller, Walter L.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (10): : 611 - 618
  • [49] The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4
    Peng, Chi-Chi
    Pearson, Josh T.
    Rock, Dan A.
    Joswig-Jones, Carolyn A.
    Jones, Jeffrey P.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 497 (1-2) : 68 - 81
  • [50] 慢性肝胆疾患P450同工酶CYP3A4表达的改变
    杨立群
    曹云飞
    俞卫锋
    李慎菁
    第二军医大学学报, 2002, (04) : 407 - 409
12345